IMAGE

Fig. 6

ID
ZDB-IMAGE-221220-51
Genes
Source
Figures for Pereira Sena et al., 2021
Image
Figure Caption

Fig. 6

Counteracting increased OGT via its pharmacological inhibition reduces polyQ-expanded ataxin-3 levels and aggregates, alleviating motor phenotype in MJD zebrafish model. (A) Western blot of samples from MJD zebrafish larvae (84Q) and its wild-type control (23Q), depicting a baseline increase of OGT in the ataxin-3 84Q fish. β-actin served as loading control. n = 9 to 10, one-sample t test, and P = 0.028. (B) Western blot demonstrating the reduction of OGT upon 16 μM OSMI-1 treatment of Atx3 84Q zebrafish. β-actin served as loading control. n = 5 and one-sample t test; in 0 versus 16 μM OSMI-1, P = 0.036. (C) Treatment of Atx3 84Q zebrafish with 16 μM OSMI-1 also reduced Atx3 full-length (red arrowhead) and cleavage products (gray arrowheads), as demonstrated on Western blot. β-actin served as loading control. n = 4 to 5, one-sample t test; in Atx3 full-length 0 versus 16 μM OSMI-1, P = 0.014; and in Atx3 cleaved 0 versus 16 μM OSMI-1, P = 0.011. (D) Representative images of the total distance swum on a tracking system by the Atx3 23Q and 84Q DMSO-treated transgenic zebrafish and the Atx3 84Q OSMI-1-treated fish at the concentrations of 8 μM and 16 μM. Images revealed a baseline impaired swimming pattern for the 84Q fish (DMSO) when compared to the 23Q fish and an improvement of the motor function in the 84Q OSMI-1-treated fish. The graph displays the quantification of the total swum distance of the transgenic zebrafish in all conditions depicted in the images. n = 184 (23Q), 247 (84Q 0 μM), 210 (84Q 8 μM), 246 (84Q 16 μM); one-way ANOVA with Dunett’s post hoc test; in 23Q versus 84Q DMSO (0 μM OSMI-1), P < 0.0001; in 84Q 0 versus 8 μM OSMI-1, P = 0.049; and in 84Q 0 versus 16 μM, P = 0.022. (E) Confocal imaging of the Atx3 84Q zebrafish spinal cord demonstrating the reduction of ataxin-3 aggregates (red arrowheads) upon OSMI-1 treatment at 16 μM (400× magnification). Scale bar, 15 μm. (F) Flow cytometric analysis of dissociated zebrafish cells expressing EGFP-tagged Atx3 84Q demonstrated the reduction of ataxin-3 aggregates (insoluble GFP+ particles) upon 16 μM OSMI-1 treatment. Nuclei of live cells were stained and identified based on the intensity of infrared fluorescence. RFU, relative fluorescence units; FSC-A (AU), forward scatter area, arbitrary unit. The graph displays the quantification of ataxin-3 aggregates at 0 μM (DMSO), 8 μM, and 16 μM OSMI-1 treatment. n = 5 to 7, one-sample t test, and P = 0.018. Data are represented as means ± SEM, *P ≤ 0.05, and ****P ≤ 0.0001.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Proc. Natl. Acad. Sci. USA